Related Experiment Video
Updated: Jun 23, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
Influence of Dietary Cobalt on Fiber Digestibility and Serum Cobalt and Cobalamin Concentrations in Horses
Rebecca Ashlee LeCompte Lazić1, Brian D Nielsen1, Cara I Robison1
1Department of Animal Science, 474 S. Shaw Lane, Michigan State University, East Lansing, MI 48824, USA.
Abstract:
The 2007 Horse NRC reduced cobalt (Co) requirements from 0.1 ppm to 0.05 ppm in dietary dry matter, though preliminary research suggested increasing dietary-Co enhanced fiber digestion in horses. This study aimed to evaluate fiber digestion with varying dietary Co amounts, as well as to compare serum Co concentrations with dietary Co content. Four geldings (mean body weight [BW] 503 ± 37 kg) were studied in a 4 × 4 Latin square design consisting of four 5-week periods, each comprising a 2-week washout phase followed by a 3-week treatment phase. Supplementing 0.0, 5.6, 16.8, or 28.0 mg of Co daily resulted in total Co dietary concentrations of 0.06, 0.7, 2.0, and 3.0 ppm, respectively. Feces and urine were collected to evaluate fiber digestibility and Co balance. Co supplementation did not affect neutral detergent fiber, acid detergent fiber, or lignin digestibility. Co balance was negative for the control diet but positive for the other three treatments (p = 0.04). Serum cobalamin concentrations slightly decreased (6%) with increasing dietary Co intake (p = 0.003), while folate concentrations were unaffected. Serum Co concentration differed (p < 0.01) with a mean of 4.7 μg/mL for the high treatment and 0.8 μg/mL for the control. Results suggest that serum Co concentrations above regulatory limits are likely due not to higher levels of Co in fortified feeds, but rather to parenteral administration of Co solutions.
Related Concept Videos
Proteins: Dietary Sources and Requirements
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Bioavailability: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

